Clinical Trial Update: Clinical Trial of Recombinant Adenovirus Type 5 AIDS Vaccine [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for a Recombinant Adenovirus Type 5 AIDS Vaccine sponsored by the CDC; the current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome

Drugs mentioned

• Recombinant Adenovirus Type 5 AIDS Vaccine (recombinant adenovirus type 5 AIDS vaccine)

Snippet

Sponsor: Centers for Disease Control and Prevention, China | Conditions: Acquired Immunodeficiency Syndrome | Phase 1 | Status: UNKNOWN